Vogelsang H - Search Results

1

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H; Vienna Hepatic Hemodynamic Lab. Reiberger T, et al. Among authors: vogelsang h. J Hepatol. 2013 May;58(5):911-21. doi: 10.1016/j.jhep.2012.12.011. Epub 2012 Dec 20. J Hepatol. 2013. PMID: 23262249

2

Screening for celiac disease in first-degree relatives of patients with celiac disease by lactulose/mannitol test.

Vogelsang H, Wyatt J, Penner E, Lochs H. Vogelsang H, et al. Am J Gastroenterol. 1995 Oct;90(10):1838-42. Am J Gastroenterol. 1995. PMID: 7572905

3

Intestinal permeability and the prediction of relapse in Crohn's disease.

Wyatt J, Vogelsang H, Hübl W, Waldhöer T, Lochs H. Wyatt J, et al. Among authors: vogelsang h. Lancet. 1993 Jun 5;341(8858):1437-9. doi: 10.1016/0140-6736(93)90882-h. Lancet. 1993. PMID: 8099141

4

Increased gastric and intestinal permeability in patients with Crohn's disease.

Wyatt J, Oberhuber G, Pongratz S, Püspök A, Moser G, Novacek G, Lochs H, Vogelsang H. Wyatt J, et al. Among authors: vogelsang h. Am J Gastroenterol. 1997 Oct;92(10):1891-6. Am J Gastroenterol. 1997. PMID: 9382060

5

Gastroduodenal permeability in Crohn's disease.

Püspök A, Oberhuber G, Wyatt J, Maier-Dobersberger T, Hammer J, Pfeffel F, Wrba F, Pötzi R, Vogelsang H. Püspök A, et al. Among authors: vogelsang h. Eur J Clin Invest. 1998 Jan;28(1):67-71. doi: 10.1046/j.1365-2362.1998.00241.x. Eur J Clin Invest. 1998. PMID: 9502189

6

Prevalence and clinical importance of hypertransaminasaemia in coeliac disease.

Novacek G, Miehsler W, Wrba F, Ferenci P, Penner E, Vogelsang H. Novacek G, et al. Among authors: vogelsang h. Eur J Gastroenterol Hepatol. 1999 Mar;11(3):283-8. doi: 10.1097/00042737-199903000-00012. Eur J Gastroenterol Hepatol. 1999. PMID: 10333201

7

Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?

Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H. Harrer M, et al. Among authors: vogelsang h. Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1281-5. doi: 10.1097/00042737-200312000-00005. Eur J Gastroenterol Hepatol. 2003. PMID: 14624150

8

Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures.

Ferlitsch A, Reinisch W, Püspök A, Dejaco C, Schillinger M, Schöfl R, Pötzi R, Gangl A, Vogelsang H. Ferlitsch A, et al. Among authors: vogelsang h. Endoscopy. 2006 May;38(5):483-7. doi: 10.1055/s-2006-924999. Endoscopy. 2006. PMID: 16767583

9

6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.

Ferlitsch A, Teml A, Reinisch W, Ulbrich G, Wrba F, Homoncik M, Gangl A, Peck-Radosavljevic M, Vogelsang H. Ferlitsch A, et al. Among authors: vogelsang h. Am J Gastroenterol. 2007 Nov;102(11):2495-503. doi: 10.1111/j.1572-0241.2007.01530.x. Epub 2007 Sep 25. Am J Gastroenterol. 2007. PMID: 17894846

10

Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection.

Koilakou S, Sailer J, Peloschek P, Ferlitsch A, Vogelsang H, Miehsler W, Fletcher J, Turetschek K, Schima W, Reinisch W. Koilakou S, et al. Among authors: vogelsang h. Inflamm Bowel Dis. 2010 Feb;16(2):198-203. doi: 10.1002/ibd.21003. Inflamm Bowel Dis. 2010. PMID: 19504611 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

444 results

Search Page

Filters